|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1997-10-9
|
|
pubmed:abstractText |
The effectiveness of antipsychotic drugs against positive psychotic symptoms has been demonstrated in many studies, but their effects on quality of life have yet to be clarified. The impact of different neuroleptic therapies on the subjective quality of life of schizophrenic patients is evaluated in a cross-sectional open study.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0007-1250
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
170
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
422-5
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9307690-Adult,
pubmed-meshheading:9307690-Analysis of Variance,
pubmed-meshheading:9307690-Antipsychotic Agents,
pubmed-meshheading:9307690-Basal Ganglia Diseases,
pubmed-meshheading:9307690-Clozapine,
pubmed-meshheading:9307690-Cross-Sectional Studies,
pubmed-meshheading:9307690-Depression,
pubmed-meshheading:9307690-Dibenzothiepins,
pubmed-meshheading:9307690-Female,
pubmed-meshheading:9307690-Humans,
pubmed-meshheading:9307690-Male,
pubmed-meshheading:9307690-Middle Aged,
pubmed-meshheading:9307690-Quality of Life,
pubmed-meshheading:9307690-Risperidone,
pubmed-meshheading:9307690-Schizophrenia,
pubmed-meshheading:9307690-Schizophrenic Psychology
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Conventional versus atypical neuroleptics: subjective quality of life in schizophrenic patients.
|
|
pubmed:affiliation |
Centre for Psychiatry, Justus-Liebig University, Giessen, Germany.
|
|
pubmed:publicationType |
Journal Article
|
